SECRETIN - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for secretin and what is the scope of freedom to operate?

Secretin is the generic ingredient in three branded drugs marketed by Ferring and Chirhoclin, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for secretin.

Summary for SECRETIN

US Patents:	0
Tradenames:	3
Applicants:	2
NDAs:	3
Drug Master File Entries:	6
Raw Ingredient (Bulk) Api Vendors:	12
Clinical Trials:	37
Patent Applications:	60
DailyMed Link:	SECRETIN at DailyMed

Recent Clinical Trials for SECRETIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National Hepatology & Tropical Medicine Research Institute	Phase 2/Phase 3
Children's Hospital Medical Center, Cincinnati	Phase 4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 4

See all SECRETIN clinical trials

Medical Subject Heading (MeSH) Categories for SECRETIN

Gastrointestinal Agents
Hormones

Anatomical Therapeutic Chemical (ATC) Classes for SECRETIN

V04CK	Tests for pancreatic function
V04C	OTHER DIAGNOSTIC AGENTS
V04	DIAGNOSTIC AGENTS
V	Various

US Patents and Regulatory Information for SECRETIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chirhoclin	SECREFLO	secretin synthetic porcine	FOR SOLUTION;INTRAVENOUS	021136-001	Apr 4, 2002		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Chirhoclin	CHIRHOSTIM	secretin synthetic human	FOR SOLUTION;INTRAVENOUS	021256-001	Apr 9, 2004		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Chirhoclin	CHIRHOSTIM	secretin synthetic human	FOR SOLUTION;INTRAVENOUS	021256-002	Jun 21, 2007		RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.